Get started
Author

Daisy Johnson

Neutralization, effector function and immune imprinting of Omicron variants
2023 · Amin Addetia, Luca Piccoli, et al. · Nature · 155
PDF
Synthetic multiantigen MVA vaccine COH04S1 protects against SARS-CoV-2 in Syrian hamsters and non-human primates
2022 · Flavia Chiuppesi, Vu H. Nguyen, et al. · npj Vaccines · 63
PDF
Therapeutic and vaccine-induced cross-reactive antibodies with effector function against emerging Omicron variants
2023 · Amin Addetia, Luca Piccoli, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 25
PDF
Vaccine-induced spike- and nucleocapsid-specific cellular responses maintain potent cross-reactivity to SARS-CoV-2 Delta and Omicron variants
2022 · Flavia Chiuppesi, John A. Zaia, et al. · iScience · 22
PDF
Cellular and humoral immunity in chronic equine laminitis
2013 · Samantha M. Steelman, Daisy Johnson, et al. · Veterinary Immunology and Immunopathology · 13
Successful outcome of pre-engraftment COVID-19 in an HCT patient: impact of targeted therapies and cellular immunity
2022 · Hoda Pourhassan, Corinna La Rosa, et al. · Blood Advances · 9
PDF
Adoptive transfer of functional SARS‐COV ‐2‐specific immunity from donor graft to hematopoietic stem cell transplant recipients
2022 · Corinna La Rosa, Flavia Chiuppesi, et al. · American Journal of Hematology · 5
Putative Protective Role of Sars-Cov-2-Specific T Cells in an HCT Patient Transplanted during Active COVID19 Infection
2022 · Hoda Pourhassan, Corinna La Rosa, et al. · Transplantation and Cellular Therapy
Works count: 8
Citation count: 292
H-index: 6
I10-index: 5
Year
Topic
Type